Track and trace medications and lobbying

This week on BGOV’s Capital Impact show hosted by Allen Scott:

  • Bipartisan legislation in both chambers of Congress would strengthen the pharmaceutical supply chain by creating a single nationwide system of tracking prescription drugs from manufacturer to end user. Bloomberg Government Senior Health Care Analyst Brian Rye discusses his latest analysis Drug Track-and-Trace Bills Would Hurt Pharmacies.
  • Second quarter lobbying results are in and in light of defense sequestration, the numbers are up from last quarter. Lots of lobbying is being done on behalf of cable tv, health care and sunscreen manufacturers. Find out more with Bloomberg Government data wizard Dr. Peter Brusoe and Bloomberg Industries analyst Melissa Avstreih on this weeks Capital Impact

(Links above require a subscription to


Allen Scott (moderator) specializes in customer on boarding and training at Bloomberg Government. Allen previously worked at Arbitron, Inc. where he served in a variety of roles from customer service to sales operations manager. Prior to Arbitron, Allen worked in radio for several years in the Washington and Baltimore areas. Most recently he spent six years at 99.1 HFS as co-host and news director.
Brian Rye is a health care financial analyst with Bloomberg Government. Before joining Bloomberg, he spent 12 years as an equity research analyst at SunTrust, Raymond James and Janney Montgomery Scott. In those capacities, he followed biotech, pharmaceutical and other health care companies. Rye also served as a senior business management analyst for Booz Allen Hamilton’s civil health group. He received a bachelor’s degree in economics from Vanderbilt University and holds the Chartered Financial Analyst designation.
Peter Brusoe Peter Brusoe is a campaign finance data analyst for Bloomberg Government. Before joining Bloomberg he was a research associate with the Campaign Finance Institute where he co-authored a number of studies examining the confluence of campaign finance law and contributions. He received a B.A. in History and Political Science from the University at Albany, SUNY, an M.A. in Political Science from the Nelson A. Rockefeller College of Public Affairs and policy and a Ph.D. in political science from American University.
Melissa Avstreih is a transportation analyst at Bloomberg Government. She had been a partner at the Ferguson Group, a consulting firm where she chaired the Transportation Practice Group. Avstreih worked as a staffer for a member of the House Transportation and Infrastructure Committee. She holds a political science degree from West Chester University and a master’s of international commerce and policy from George Mason University.